Role of PI3K, MAPK/ERK 1/2, and p38 in Production of Erythropoietic Activity by Bone Marrow Cells after Blood Loss


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The leading role in the regulation of erythropoietic activity of adherent bone marrow cells under conditions of post-hemorrhagic anemia is played by classical MAP kinase pathway (ERK pathway). Erythropoietin is not the decisive factor in the formation of erythropoietic activity of adherent cells. PI3K, MAPK/ERK 1/2, and p38-signaling proteins are not the main regulators of local production of erythropoietin after 30% loss of circulating blood volume.

About the authors

V. V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

L. A. Miroshnichenko

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Author for correspondence.
Email: laarmi@yandex.ru
Russian Federation, Tomsk

E. V. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

G. N. Zyuz’kov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

T. Yu. Khrichkova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

E. V. Simanina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

E. Yu. Sherstoboev

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

L. A. Stavrova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

V. I. Agafonov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

A. V. Chaikovskii

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

M. Yu. Minakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk

A. M. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Russian Federation, Tomsk


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies